CLEC4M Is Associated With Poor Prognosis and Promotes Cisplatin Resistance in NSCLC Patients

Journal of Cancer - Australia
doi 10.7150/jca.30139
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ivyspring International Publisher


Related search